Wellington Shields & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wellington Shields & Co’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$617K	Hold	3,900	–	–	0.14%	141
2026 Q1	$498K	Hold	3,900	–	–	0.13%	146
2025 Q4	$476K	Hold	3,900	–	–	0.12%	146
2025 Q3	$391K	Hold	3,900	–	–	0.1%	162
2025 Q2	$323K	Hold	3,900	–	–	0.09%	170
2025 Q1	$316K	Hold	3,900	–	–	0.1%	169
2024 Q4	$351K	Hold	3,900	–	–	0.11%	158
2024 Q3	$385K	Hold	3,900	–	–	0.12%	150
2024 Q2	$362K	Hold	3,900	–	–	0.12%	150
2024 Q1	$370K	Hold	3,900	–	–	0.12%	154
2023 Q4	$348K	Hold	3,900	–	–	0.13%	147
2023 Q3	$285K	Buy	+3,900	New	+$312K	0.07%	163
2023 Q2	–	Sell	-3,900	Closed	-$297K	–	303
2023 Q1	$297K	Hold	3,900	–	–	0.07%	164
2022 Q4	$324K	Hold	3,900	–	–	0.07%	147
2022 Q3	$309K	Sell	3,900 -700	-15%	-$59K	0.13%	142
2022 Q2	$342K	Buy	4,600 +700	+18%	+$52.5K	0.08%	137
2022 Q1	$351K	Hold	3,900	–	–	0.12%	148
2021 Q4	$437K	Hold	3,900	–	–	0.09%	138
2021 Q3	$490K	Hold	3,900	–	–	0.17%	114
2021 Q2	$528K	Hold	3,900	–	–	0.17%	110
2021 Q1	$529K	Hold	3,900	–	–	0.19%	102
2020 Q4	$549K	Hold	3,900	–	–	0.2%	92
2020 Q3	$435K	Hold	3,900	–	–	0.18%	102
2020 Q2	$437K	Hold	3,900	–	–	0.19%	103
2020 Q1	$302K	Hold	3,900	–	–	0.17%	119
2019 Q4	$371K	Buy	+3,900	New	+$337K	0.16%	119
2019 Q3	–	Sell	-3,900	Closed	-$342K	–	210
2019 Q2	$342K	Hold	3,900	–	–	0.16%	124
2019 Q1	$353K	Hold	3,900	–	–	0.18%	120
2018 Q4	$280K	Hold	3,900	–	–	0.16%	124
2018 Q3	$374K	Hold	3,900	–	–	0.2%	97
2018 Q2	$371K	Sell	3,900 -1,245	-24%	-$114K	0.19%	96
2018 Q1	$451K	Buy	5,145 +1,000	+24%	+$91.3K	0.24%	90
2017 Q4	$352K	Buy	4,145 +45	+1%	+$3.77K	0.19%	104
2017 Q3	$355K	Hold	4,100	–	–	0.12%	98
2017 Q2	$316K	Sell	4,100 -775	-16%	-$55K	0.11%	96
2017 Q1	$338K	Sell	4,875 -603	-11%	-$40.5K	0.1%	88
2016 Q4	$324K	Hold	5,478	–	–	0.17%	88
2016 Q3	$363K	Hold	5,478	–	–	0.18%	74
2016 Q2	$296K	Buy	5,478 +1	+0%	+$55	0.18%	81
2016 Q1	$283K	Buy	5,477 +1	+0%	+$52	0.19%	78
2015 Q4	$384K	Buy	+5,476	New	+$373K	0.25%	59

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Wellington Shields & Co's XBI Position: Q2 2026 in Review

Wellington Shields & Co held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 3,900 shares worth $617K. The position accounts for 0.14% of the portfolio, ranked #141.

Wellington Shields & Co first reported a position in XBI in Q4 2015 and has held it in 41 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Wellington Shields & Co held 3,900 shares of State Street SPDR S&P Biotech ETF worth $617K as of Q2 2026.
Wellington Shields & Co left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.14% of Wellington Shields & Co's portfolio in Q2 2026, its #141 holding.
Wellington Shields & Co first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and has held it in 41 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.